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The biological properties of poxvirus isolates from skin lesions on dairy cows and milkers during recent exanthem
episodes in Cantagalo County, Rio de Janeiro State, Brazil, were more like vaccinia virus (VV) than cowpox virus. PCR
amplification of the hemagglutinin (HA) gene substantiated the isolate classification as an Old World orthopoxvirus, and
alignment of the HA sequences with those of other orthopoxviruses indicated that all the isolates represented a single strain
of VV, which we have designated Cantagalo virus (CTGV). HA sequences of the Brazilian smallpox vaccine strain (VV-IOC),
used over 20 years ago, and CTGV showed 98.2% identity; phylogeny inference of CTGV, VV-IOC, and 12 VV strains placed
VV-IOC and CTGV together in a distinct clade. Viral DNA restriction patterns and protein profiles showed a few differences
between VV-IOC and CTGV. Together, the data suggested that CTGV may have derived from VV-IOC by persisting in an
indigenous animal(s), accumulating polymorphisms, and now emerging in cattle and milkers as CTGV. CTGV may represent
the first case of long-term persistence of vaccinia in the New World. © 2000 Academic Press
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The family Poxviridae contains complex cytoplasmic
DNA viruses that replicate in vertebrate and invertebrate
hosts. Members of the poxvirus genus Orthopoxvirus
include several pathogens of human and veterinary im-
portance that replicate in vertebrate cells and show ex-
tensive serologic cross-reactivity and genome DNA
cross-hybridization (Esposito and Fenner, in press;
Moss, 1996).
The human orthopoxviruses comprise variola, mon-
keypox, cowpox, and vaccinia viruses. Variola virus, the
cause of smallpox, a systemic disease with generalized
rash, was eradicated from the world population by 1977,
primarily by vaccination using the orthopoxvirus, vac-
cinia virus (Fenner et al., 1988). Monkeypox virus, the
cause of a zoonotic smallpox-like disease of low inter-
human transmissibility, is contracted from infected ani-
mals, most likely squirrels indigenous to Central and
West African rainforests, mainly the Democratic Republic
of Congo (Heymann et al., 1998; Esposito and Fenner, in
press). Cowpox virus (CPV), the cause of a localized,
rather painful vesicular lesion, is believed to persist in a
reservoir comprising various rodents indigenous to parts
of Europe and adjoining Asia; cattle, zoo animals, and,
† In memory of Dr. Carlos Chagas Filho (1910–2000).
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dressed. Fax: 55 21 280-8193. E-mail: nissin@biof.ufrj.br.
439very often, domestic cats comprise intermediate infected
hosts, which may transmit the virus to humans (Baxby et
al., 1979; Chantrey et al., 1999; Meyer et al., 1999). Vac-
inia virus (VV) is the prototypic member of the Orthopox-
irus and its origins are obscure and still a matter of
iscussion (Baxby, 1977; Esposito and Fenner, in press).
imilar to CPV, VV infection usually causes localized
egions at the site of inoculation. Some strains of VV
sed for manufacture of smallpox vaccine caused side
ffects, such as generalized or progressive vaccinia or
ncephalitis (Esposito and Fenner, in press). Smallpox
accination was discontinued worldwide, except by cer-
ain militaries, by the early 1980s (Fenner et al., 1988).
uring mass vaccination campaigns, VV infections were
ccasionally transmitted from the vesicular lesion on the
accinee to domestic animals, usually cattle, and in turn,
nfected animals transmitted VV to susceptible people.
everal outbreaks in cattle and humans of what was
hought to be cowpox were indeed caused by VV (Malt-
eva et al., 1966; Lum et al., 1967; Topciu et al., 1976).
Buffalopox virus (BPV), which has an unknown natural
history, is a subspecies of VV that causes localized
lesions on milking buffalo, dairy cattle, and local and (by
drinking unpasturized milk) oropharyngeal lesions on
humans (Dumbell and Richardson, 1993; Kataria and
Singh, 1970); clinically BPV lesions are similar to cowpox
vesicles, though less painful lesions of mild cases re-
semble VV vesicles. BPV outbreaks were first noted
during the smallpox vaccination era in India, Egypt, and
0042-6822/00 $35.00
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440 DAMASO ET AL.Indonesia, but more recently are reported mostly from
India (Mathew, 1967; Kolhapure et al., 1997). BPV is
considered a VV subspecies because it is the only VV
currently known to be established in nature (Esposito
and Fenner, in press).
In the present report, we describe another potential
established VV, which was isolated recently from lesion
samples taken during episodes of exanthem affecting
dairy cattle and milkers on several farms in the county of
Cantagalo, state of Rio de Janeiro, Brazil; we designated
the virus Cantagalo virus (CTGV). This report shows the
sequences for the gene encoding the hemagglutinin
(HA) protein and the results of a phylogenetic analysis,
which indicated that CTGV is closely related to VV-IOC, a
smallpox vaccine strain manufactured by Instituto Os-
waldo Cruz and used to eradicate smallpox from the
region over 20 years ago. Though VV-IOC and CTGV
appeared rather closely related by HA sequence analy-
sis, DNA restriction cleavage patterns and viral protein
SDS–PAGE profiles suggested that several polymor-
phisms have developed over the years, presumably via
VV-IOC adaptation into nature. Our results, obtained al-
most 20 years after cessation of smallpox vaccination,
may provide a sole example of long-standing persis-
tence of VV virus in the New World, analogous to buffa-
lopox in India.
RESULTS
Biological and morphological features of CTGV
During the last half of 1999, an outbreak of exanthem
was observed in dairy cattle on several farms in the
counties of Cantagalo, Santo Antoˆnio de Pa´dua, Mira-
cena, among others, in the northwestern part of Rio de
Janeiro State, Brazil. The clinical features resembled
those of cowpox, including papules on the teats and
udders that progressed from vesicle to pustule and
healed within 3 weeks, leaving a scar. Secondary infec-
tion—mastitis—was observed in some cows. The vesic-
ular disease apparently was transmitted to several milk-
ers and family members, who reported or showed le-
sions on the hands and/or forearms, accompanied by
high fever, malaise, and axillary lymphadenopathy; a few
severe cases had generalized vesicular lesions on their
bodies.
Vesicular fluid of a cow’s lesion provided an isolate,
which we refer to henceforth as CTGV, produced whitish,
opaque pocks that measured 2–2.8 mm on choriallantoic
membranes (CAMs) by the fourth day postinfection (data
not shown). The CTGV pocks were identical to pocks
produced using VV-WR, but were readily distinguished
from CPV hemorrhagic red lesions.
The supernatant fluid of macerated, centrifugally clar-
ified CAMs that had been infected with CTGV was used
to infect Hep-2 cell cultures; after 24 h of incubation,
infected cells were collected for electron microscopy.Ultrathin sections showed CTGV particles with brick-
shaped virion morphology, including a biconcave core
surrounded by the outer membrane (Figs. 1A and 1B). At
24 h, all the typical stages of poxvirus morphogenesis
were apparent in the infected cells, which contained
numerous mature virus particles (Figs. 1C and 1D) in the
cytoplasm. Immature particles were in the proximity of
the viroplasm (Fig. 1E and inset) in various morphoge-
netic stages, including cup-shaped crescents (cupulae),
spherical particles, and particles with nucleoids.
CTGV production in various cell lines was examined at
48 h postinfection, when infected cells were disrupted by
two freeze–thaw cycles to determine plaque titers using
BSC-40 cell monolayers. Table 1 shows the virus yield
(standardized for 1 3 106 cells) from different cell lines; of
the cell lines tested, Hep-2 and rat glioma C6 cells
produced the highest infectious virus titer.
Detection of ATI protein
The morphology of CTGV on CAMs strongly suggested
that the isolate was not CPV, in addition to the fact that
the geographical distribution of CPV appears restricted
to animals indigenous to parts of Europe and adjoining
Asian countries (Chantrey et al., 1999). To further estab-
lish CTGV properties, a characteristic feature of CPV, the
presence of acidophilic type inclusions (ATIs), was able
to be ruled out morphologically by electron microscopy
(Fig. 1) and biochemically by determining the molecular
weight of the CPV ATI protein by Western blot (Fig. 2).
Typically, the CPV ATI protein is ;160 kDa and shows
several truncated forms by Western blot assay (Patel et
al., 1986; Knight et al., 1992; Fig. 2, lane 7); however,
examination of Western blots of lysates of C6 cells in-
fected for 24 h with CTGV showed a 94-kDa truncated
protein (Fig. 2, lanes 2 and 3), which is typical of VV
strains (lanes 4–6) and some other orthopoxviruses (Am-
egadzie et al., 1992).
HA gene sequence
The HA gene encodes a glycoprotein that can be
detected on the infected cell plasma membrane and on
the tegument covering the outer membrane of extracel-
lular enveloped virions. The glycoprotein is synthesized
late in infection by orthopoxviruses, and no other poxvi-
rus genus encodes such a gene, which makes the pres-
ence of antibodies against the HA protein a good indi-
cator of orthopoxvirus infections (Esposito and Fenner, in
press; Nakano and Esposito, 1989; Shida, 1989). To fur-
ther establish CTGV features, the presence of the HA
gene was determined in the CTGV genome using meth-
ods described by Ropp et al. (1995), which identify and
differentiate orthopoxviruses using PCR. For this method,
specific primers described by Ropp et al. (1995) were
made to enable differentiation of Eurasian–African or-
thopoxviruses from North American orthopoxviruses.
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441CANTAGALO VIRUS, AN EMERGENT POXVIRUSFigure 3 shows an 850-bp amplicon from CTGV DNA
using such primers to identify the Eurasian–African or-
thopoxviruses (Fig. 3, EACP primers, lanes 2–4), and no
fragments were amplified using NACP primers specific
for North American orthopoxviruses. DNA isolated from
raccoonpox was used as a positive control for the PCR
assay using the NACP primers (Fig. 3, lane 7). Lanes 5
and 6 of Fig. 3 show that the EACP primers were able to
amplify the positive-control DNAs from VV-WR and CPV,
confirming the results of Ropp et al. (1995).
Because differences exist among HA gene sequences
FIG. 1. Analysis of CTGV particle morphology and morphogenesis b
an m.o.i. of 5 and at 24 h postinfection, the monolayers were fixed and p
and Methods. Representative fields were photographed. Typical brick-s
are seen in detail at higher magnification (A and B). Intracellular mature
within the virosomes (C). Increased magnification of IMVs (D). The earl
electron-dense viral factories (F) associated with crescents (Cr), sphe
nucleus.f different orthopoxviruses, which are useful for phylo-
enetic analysis (Esposito and Fenner, in press; Ropp et
f
pl., 1995), the base sequences of the CTGV HA gene
ere determined using primers HAOUTF and HAOUTR
o amplify the CTGV HA gene a few bases outside of the
pen reading frame, comprising a 1180-bp amplicon,
hich included 927 nucleotides of the HA open reading
rame; both strands of the amplicon DNA were se-
uenced using primers described under Materials and
ethods. When the HA deduced amino acid sequences
ere aligned with other orthopoxvirus HA amino acid
equences from GenBank (Fig. 4), variations were noted,
ncluding the putative amino acid content that derived
hin sections of infected cells. Hep-2 cells were infected with CTGV at
ed for transmission electron microscopy as described under Materials
mature particles with central biconcave core surrounded by envelopes
(IMV) are visualized in several areas of the cytoplasm of infected cells
s of normal virion morphogenesis are also visualized (E and inset): the
mature particles (IV), and immature particles with nucleoid (IVnu). N,y ultrat
rocess
haped
virions
y stagerom differences near the carboxyl terminal of the HA
rotein. As shown in Fig. 4, a sequence of six amino
m
(
m
442 DAMASO ET AL.acids (DTYNDN; positions 251 to 256, shaded area in Fig.
4) was absent in the CTGV HA that was present in all
other orthopoxviruses examined, with the exception of
RPV, which lacked two of the six amino acids (ND) and
variola major, which showed a Y to H substitution in
these sequences.
The HA gene of an isolate from human lesion material
obtained during an outbreak that occurred simulta-
neously in Santo Antoˆnio de Pa´dua County, RJ, Brazil,
was also sequenced and revealed 100% identity with the
CTGV HA sequences (data not shown), indicating that
the human infection was probably also caused by CTGV.
Analysis of the HA sequence pairwise alignment (Fig.
4) suggested that CTGV was indeed a VV strain; thus, we
decided to add to our comparison the HA sequence of a
VV strain that was used to make smallpox vaccine used
TABLE 1
CTGV Production in Different Cell Lines
Cell line PFU/ml/106 cells
CEF 1.5 3 108
Hep-2 1.5 3 108
C6 7.9 3 107
MDCK 3.6 3 107
Vero 3.3 3 107
BSC-40 2.9 3 107
NIH-3T3 3.9 3 106
Note. Cell monolayers were infected with 1 PFU/cell of CTGV for 1 h.
After adsorption, the monolayers were rinsed and incubated with fresh
medium and after 48 h of infection the cells were harvested for virus
titration by plaque assay in BSC-40 cells. Data are expressed as virus
infectious particles (PFU/ml) produced by 1 3 106 cells.
FIG. 2. Detection of CTGV ATI protein by Western blot. C6 cells were
ock-infected (lane 1) or infected with CTGV (lanes 2 and 3), VV-IOC
lane 4), VV-NYBH Wyeth (lane 5), VV-WR (lane 6), and CPV (lane 7) at
.o.i. 5 1. At 24 h postinfection, cell extracts were prepared and
examined by 10% SDS–PAGE. Proteins were transferred to nitrocellu-
lose filters and processed for immunological detection with anti-CPV
ATI serum, as described under Materials and Methods. Arrow points to
the 160-kDa ATI protein accumulated in CPV-infected cells.in the region during the eradication campaign in the
1960s and 1970s in Brazil. For this analysis, we selected
a VV strain available from the Instituto Oswaldo Cruz
(IOC), which we named strain VV-IOC; inquiries indicated
that the exact origin of the master seed for manufacture
of VV-IOC-based vaccine was uncertain. To determine
whether VV-IOC and CTGV were related, the VV-IOC HA
gene was amplified and sequenced as described before.
Figure 4 shows that the HA amino acid sequences of
VV-IOC were like CTGV in that they lacked the DTYNDN
sequences. Alignment of the CTGV and VV-IOC base
sequences showed 98.2% identity and the amino acid
sequence identity was 96.7%.
We inferred the phylogeny of the HA sequences using
Puzzle 4.02 (Strimmer and von Haeseler, 1997) as de-
scribed under Materials and Methods. Figure 5 shows
the results, which placed VV-IOC and CTGV HAs within
the same clade. Using the genetic distance scale in Fig.
5, the nearest related HAs were (in order of proximity)
VV-Lenny, VV-Lister, VV-Copenhagen, VV-koppe, rabbit-
pox u23, rabbitpox utr, VV-ihdj, VV-ihdw, VV-tt, and VV-WR,
which segregated into branches distinct from the cluster
containing CTGV and VV-IOC. The data supported the
view that CTGV is a VV strain, probably derived from the
Brazilian smallpox vaccine strain VV-IOC.
DNA restriction digest and cross-hybridizations
FIG. 3. Identification of CTGV as a Eurasian–African orthopoxvirus by
HA amplification. Virus DNA was isolated from infected cells and used
in PCRs for HA amplification. PCR mixtures contained consensus
sequence primers NACP1 and NACP2 (North American orthopoxvi-
ruses) or EACP1 and EACP2 (Eurasian–African orthopoxviruses), as
described under Materials and Methods. HA amplicons visualized in
the PCRs are approximately 850–950 bp (EACP primers), except for
RCN DNA, approximately 650 bp (NACP primers). Lanes: (1) no DNA; (2)
CTGV (DNA isolation 1); (3) CTGV (DNA isolation 2); (4) CTGV (DNA
isolation 3); (5) VV-WR; (6) CPV; (7) RCN. Lane M, DNA size marker 1-kb
ladder (BRL/Life Technologies).To further determine whether physical genetic differ-
ences exist between CTGV and VV-IOC, restriction digest
a
a
443CANTAGALO VIRUS, AN EMERGENT POXVIRUSelectrophoresis profiles and Southern blots were gener-
ated essentially as described for differentiating and map-
ping other orthopoxviruses (Wittek et al., 1977; Mackett
nd Archard, 1979; Esposito and Knight, 1985; Knight et
l., 1989). Cross-hybridization of HindIII and SalI restric-
tion digest electropherogram blots of CTGV and VV-IOC
showed that CTGV and VV-IOC DNA fragments cross-
hybridize extensively with either VV-IOC (Fig. 6A) or
VV-WR (Figs. 6B–6D) radiolabeled probe DNAs (Figs. 6A
and 6B (HindIII digest) and 6C and 6D (SalI digest), lanes
1 (CTGV) and 2 (VV-IOC). Despite the overall conserva-
tion of HindIII cleavage sites, two distinctive fragments
appeared in the CTGV HindIII electropherograms that
distinguished it from VV-IOC (Fig. 6A, lane 1): the pres-
ence of an ;17-kb (arrow) fragment and a 5-kb, possible
2 M fragment (arrowhead) was observed in CTGV. HindIII
digests when cross-hybridized with radiolabeled VV-WR
DNA revealed a pattern identical to that described above
(data not shown). Figure 6B shows a more detailed view
of the larger HindIII fragments, highlighting the differ-
ence between CTGV and VV-IOC compared with VV-
NYBH Wyeth and VV-WR. Differences between CTGV and
VV-IOC genomes were also evidenced using SalI (Fig.
6C, lanes 1 and 2), which shows several unique restric-
tion fragments of CTGV DNA compared with the other
viruses examined (Fig. 6D shows an enlarged view). The
HA similarity and the restriction data indicating several
cleavage site differences, particularly in the SalI profile,
suggested that CTGV and VV-IOC indeed are separate
strains, but it may be that CTGV derived from VV-IOC.
Analysis of viral proteins
To determine whether the differences in the restriction
profiles of CTGV and VV-IOC translated to viral protein
differences, SDS–PAGE Western blot profiles were exam-
ined for viral proteins that accumulated late in infection
of C6 cells with CTGV, VV-IOC, VV-NYBH Wyeth, VV-WR,
and CPV using a polyclonal antiserum against proteins
of highly purified VV-WR intracellular mature virions
(IMVs) (Damaso and Moussatche´, 1998). Figure 7 shows
substantial cross-reactivity of the serum with each virus
in the assay, including CPV (no proteins were recognized
FIG. 4. Comparative amino acid alignments of the putative CTGV and
VV-IOC HA gene to other HA genes. The alignments were done using
the PILE-UP program (GCG Wisconsin package). The orthopoxvirus
sequences compared were from Variola minor-Garcia 1966 (var); VV-L-
IVP-1 (livp); VV-NYBH Wyeth (wyeth); VV-WR (wr); VV-IOC (IOC); Canta-
galo virus (CTGV); rabbitpox Ultrech (rbt); cowpox GRI-90 (cpv); mon-
keypox Zaire 77-0666 (mkp); and Ectromelia-K1 (ect). Except for CTGV
and VV-IOC sequences described in this paper (GenBank Accession
Nos. AF229247 and AF229248), all other sequences were obtained
from GenBank, as described under Materials and Methods. The
shaded area represents the conserved amino acids in the HA proteins,
which are missing in CTGV and VV-IOC. The boxed area represents the
differences in amino acids between VV-IOC and CTGV.
444 DAMASO ET AL.by the antiserum using blots of mock-infected cells (Fig.
7A, lane 1). Overall, the Western blots of the different
viruses used appeared rather similar for cells at 24 h
postinfection (Fig. 7), except for immunodominant pro-
teins that migrated in the range of 35 to 49 kDa (range
demarcated in Figs. 7A–7C). The blots showed an immu-
nodominant viral protein of the cow or human isolates of
FIG. 5. Inferred phylogeny of vaccinia viruses. The open reading
frame sequences (;971 bp) coding for the hemagglutinin (HA) protein
of different vaccinia virus strains and isolates were compared by
constructing an unrooted tree using Clustal X-aligned base sequences
for input into the maximum-likelihood software Puzzle 4.02 (Strimmer
and von Haeseler, 1997), opting for the Hasegawa model of substitu-
tion, neighbor-joining, a uniform rate heterogeneity model, and buffa-
lopox virus (bfl 81) as the outgroup, and 10,000 tree-puzzling steps to
obtain quartet maximum-likelihood trees and a quartet puzzling tree
with statistically significant taxon partition frequencies; the scale rep-
resents relative genetic distance. Virus sequences used for the anal-
ysis were vaccinia strains Lister (vac-lst); Statens Serum Institute
Copenhagen (vac-koppe); Lenny (vac-len), Copenhagen (GenBank Ac-
cession No. M35027) (vac-cpn); Western Reserve (vac-wr); International
Health Department variants (vac-ihdw and vac-ihdj); Chinese Tian Tan
(vac-tt); rabbitpox Utrecht (rpv-utr); mutant rabbitpox (rpv-u23); buffa-
lopox isolates (bfl-3906 and bfl-81); VV-IOC (ioc); and CTGV (ctgv).
Except for VV-IOC and CTGV described in this paper, the origins of the
viruses are described elsewhere (Esposito and Fenner, in press; Es-
posito and Knight, 1985; Meyer et al., 1997; Ropp et al., 1995).CTGV migrating at 40 kDa (Figs. 7A and 7B, lanes 2 and
3, arrow), whereas VV-IOC, VV-NYBH Wyeth, and VV-WRshowed an immunodominant protein of 43 kDa (Figs. 7A
and 7B, lanes 4, 5, and 6, respectively), and CPV showed
an immunodominant protein at 45 kDa (Figs. 7A and 7B,
lane 7). In addition to the immunodominant protein in this
region, VV-IOC showed a minor protein comigrating with
the 40-kDa CTGV protein (seen best in Fig. 7B, arrow),
which is absent in the VV-NYBH Wyeth and VV-WR pro-
files. When purified IMVs of CTGV, VV-IOC, and VV-WR
were used for Western blotting, the antiserum reacted
similarly. Major profile differences were observed in the
35- to 49-kDa gel region (Fig. 7C). CTGV showed a
40-kDa immunodominant species as in the cell lysates,
whereas VV-IOC and VV-WR showed a 43-kDa species,
but VV-IOC also showed a minor 40-kDa species. The
observation of a 40-kDa species that was a major protein
in CTGV and a minor protein in VV-IOC suggested a
similarity between these strains. On the other hand, the
observation that VV-IOC contained a major 43-kDa spe-
cies, like VV-NYBH Wyeth and VV-WR, indicated a diver-
gence. Together with the HA data, the protein profiles
suggested that CTGV may have originated from VV-IOC.
DISCUSSION
The present study describes characteristics of a newly
discovered orthopoxvirus, CTGV, which was isolated
from cows and milkers in 1999 during an exanthem
outbreak on farms in Rio de Janeiro State, Brazil. The
morphology of pocks on infected CAMs, the observation
of an ATI protein of ;94 kDa (Fig. 2), the presence of an
HA gene by PCR assay and alignment of HA sequences
and phylogenetic assay (Figs. 3 to 5), and restriction
digest profiles (Fig. 6) provided evidence that CTGV is a
strain of VV and not CPV or another orthopoxvirus spe-
cies (Esposito and Fenner, in press; Ropp et al., 1995;
Meyer et al., 1999). We compared CTGV with a few other
VV strains, particularly VV-IOC, which was used in the
region for smallpox vaccination over 20 years ago. In
light of our present data, it appears that CTGV and
VV-IOC are as similar and as different as one strain of VV
is to another, and how CTGV was introduced in nature is
a matter for speculation.
The HA PCR assay was particularly useful as a rapid
assay and an initial step to identify this orthopoxvirus
from a variety of others. Using phylogenetic assay of the
HA sequences was reported as an effective means to
infer their relationships (Ropp et al., 1995). When we
determined the CTGV HA nucleotide and amino acid
sequences and then aligned these sequences with
those of other orthopoxviruses, there was a strong sim-
ilarity with HA sequences of different VV strains (Fig. 4),
particularly the smallpox vaccine strain VV-IOC, which
showed 98% identity compared with CTGV HA se-
quences and contained an identical deletion beginning
at amino acid position 251. The result suggested to us
that CTGV may very well be a derivative of VV-IOC.
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445CANTAGALO VIRUS, AN EMERGENT POXVIRUSBased on phylogenetic assay of the selected HA se-
quences (Fig. 5), VV Lenny, Lister, and Copenhagen were
the nearest neighbors to CTGV and VV-IOC. VV-Lenny
was isolated from a Nigerian woman who developed an
illness similar to eczema vaccinatum (Bourke and Dum-
bell, 1972), and VV-Lenny resembles the VV-NYBH Wyeth
FIG. 6. Cross-hybridization analysis of CTGV and VV-IOC DNA dige
(lanes 4) DNAs were isolated from virus-infected C6 monolayers and d
nd Methods. Southern blots were hybridized stringently with 32P-labe
detailed visualization of the large size fragments obtained with HindIII
arrowhead indicates the 5-kb fragment, which appeared exclusively in
FIG. 7. Detection of CTGV and VV-IOC structural proteins by Weste
uman lesion (lane 2), CTGV from cow lesion (lane 3), VV-IOC (lane 4),
4 h postinfection, cell extracts were prepared for electrophoresis in
rocessed for immunoblotting using antiserum raised against total p
ethods. (B) The samples used in A were analyzed in a duplicate Wes
f time to allow a detailed visualization of the polypeptides migrating in t
and proteins were detected by Western blot using the antiserum described ab
to the 43-kDa polypeptide present in VV-WR, VV-NYBH Wyeth, and VV-IOC. Arvaccine strain, which was used for vaccination at that
time in Nigeria (Fenner et al., 1988). An inquiry into the
rigin of VV-IOC, which was used by the Instituto Os-
aldo Cruz (Rio de Janeiro, Brazil) to produce the vaccine
sed during the Brazilian campaign to eradicate small-
ox (Fenner et al., 1988), was not successful, since there
GV (lanes 1), VV-IOC (lanes 2), VV-NYBH Wyeth (lanes 3), and VV-WR
with HindIII (A and B) or SalI (C and D), as described under Materials
A from purified VV-IOC (A) and VV-WR (B, C, and D). B and D show a
lI DNA digestion, respectively. Arrow points to the 17-kb fragment and
GV HindIII restriction profile.
(A) C6 cells were mock-infected (lane 1) or infected with CTGV from
H Wyeth (lane 5), VV-WR (lane 6), and CPV (lane 7) at m.o.i. 5 1. After
S–PAGE. Proteins were transferred to nitrocellulose membranes and
of highly purified VV-WR virions, as described under Materials and
ot assay, except that the membrane was exposed for a shorter period
e of 35 to 49 kDa. (C) Purified IMVs (3 3 109 particles) were solubilizedsts. CT
igested
led DNrn blot.
VV-NYB
10% SD
roteins
tern bl
he rangove. (Lane 1) CTGV, (lane 2) VV-IOC, (lane 3) VV-WR. Arrowhead points
row points to the 40-kDa protein present in CTGV and VV-IOC.
446 DAMASO ET AL.was no other information on VV-IOC, except that it orig-
inally came from France at a time of intense worldwide
collaboration to eradicate smallpox (Herman Schatz-
mayr, personal communication).
Although the HA sequences provided evidence of a
relationship of CTGV and VV-IOC, DNA restriction digest
analysis indicated nucleotide polymorphisms between
these two virus genome DNAs (Fig. 6). In this regard, SalI
was particularly useful for establishing that several poly-
morphisms and that extensive genome DNA sequencing
would be needed to fully resolve all the differences and
the levels of synonymous and nonsynonymous DNA
changes between CTGV and VV-IOC. Since CTGV may
alternatively represent a VV strain introduced from an-
other unknown source, further sequence data and phy-
logenetic analyses will be needed to more precisely
resolve the physical genetic relation of CTGV to VV-IOC
and other VV strains.
Examination of CTGV and VV-IOC proteins (Fig. 7) late
in infection was consistent with the idea that DNA poly-
morphisms over the years have led to protein coding
differences between CTGV and VV-IOC, if VV-IOC is the
progenitor. In this regard, in comparing the Western blot
protein profiles of VV-IOC, CTGV, and other VV strains,
we noted an immunodominant protein migrating be-
tween 35 and 49 kDa; the CTGV correlate of 40 kDa was
the fastest migrating species. VV-IOC also showed a
40-kDa protein, but in VV-IOC this protein was repre-
sented as a minor species and the major correlate was
43 kDa, similar to an immunodominant protein of VV-
NYBH Wyeth and VV-WR (a mouse-adapted derivative of
VV-NYBH Wyeth). Other researchers have reported dif-
ferences in orthopoxvirus proteins in the 35- to 49-kDa
region (Pennington, 1973; Esposito et al., 1977), which is
the region of migration of a VV surface glycoprotein in the
VP6 complex (Moss et al., 1973). We are currently further
examining the variable-migrating proteins.
It is interesting to speculate how CTGV was intro-
duced in nature. The last case of smallpox in Brazil
occurred in April 1971 and the systematic vaccination
continued until 1973. After that, a routine civilian vacci-
nation was sustained until the late 1970s (Fenner et al.,
1988). It may be that CTGV persisted in the wild for at
least 20 years and established effective transmission
cycles in an undetermined indigenous animal(s), which
has transmitted CTGV to milking cows and from cows to
the milkers. It is not known whether other outbreaks
occurred in the region before 1999; no official reports
have been filed with the Brazilian Ministry of Agriculture
(Georgina Lage, personal communication). Cases of so-
called “cowpox” were not unusual in the area during the
1960s (Isaac Moussatche´, personal communication); the
causative agent of such cases had never been investi-
gated and we could not assume it was or was not CTGV.
Likely, it was VV passing between smallpox vaccinees
and cattle and not true cowpox, which appears to existonly in parts of Europe and adjoining Asia and is main-
tained by indigenous animals, e.g., voles and field mice
(Chantrey et al., 1999).
During the smallpox vaccination campaign, it was rel-
atively common to have domestic animals infected with
VV by recently vaccinated individuals (Maltseva et al.,
1966; Lum et al., 1967; Topciu et al., 1976). In 1964, more
than 400 cows and 20 milkers had been infected in a
dairy farm in El Salvador and the source was a recently
vaccinated milker (Lum et al., 1967). However, in those
days, most VV accidental cases were events with no
recurrence, and the incidence of such transmission is
believed to have ceased with the suspension of smallpox
vaccination worldwide (Fenner et al., 1988). At one time it
was thought that long-term persistence of VV in nature
was a rare phenomenon; however, with eradication
came the emergence of BPV, which causes vaccinia-like
lesions on milking buffalo, dairy cattle, and humans in
contact with such infected animals. Outbreaks of BPV
still occur in India, where it has become a major occu-
pational zoonotic infection with important economic con-
sequences (Dumbell and Richardson, 1993; Kolhapure et
al., 1997). Currently, there are not enough data to esti-
mate the economical impact of CTGV on the agricultural
community; a survey is needed, since CTGV may repre-
sent an emerging viral zoonosis like BPV.
In conclusion, we have reported a novel example of
the possible long-term persistence of VV in nature in
Brazil, although we do not exclude its origin otherwise.
However, if CTGV originated from the Brazilian vaccine
strain VV-IOC or some other VV vaccine that established
itself in the wild and has now become CTGV possibly via
transmission cycles in one or more hosts, then the con-
cept of VV in nature beyond BPV should be carefully
revisited with appropriate molecular epidemiologic tools.
This is particularly important since several countries are
using VV expressing the rabies glycoprotein to vaccinate
wildlife against rabies (Boulanger et al., 1996; Brochier et
al., 1996; Pastoret and Brochier, 1999).
MATERIALS AND METHODS
Cells and viruses
BSC-40, Vero, Hep-2, C6, NIH-3T3, CEF, and MDCK
cells were propagated at 37°C in Dulbecco’s modified
Eagle’s medium (DMEM; Gibco BRL Laboratories) sup-
plemented with 8% calf serum, 2% heat-inactivated fetal
bovine serum, 25 mg/ml fungizone, 500 U/ml penicillin,
100 mg/ml streptomycin, and 50 mg/ml gentamycin.
VV strain WR was propagated in BSC-40 cells as
described elsewhere (Damaso and Moussatche´, 1992).
Ampules of lyophilized vaccine containing VV strains
New York Board of Health Wyeth (Wyeth Laboratories)
and VV-IOC (Instituto Oswaldo Cruz, RJ, Brazil) had been
kindly provided in 1981 to the Instituto de Biofisica Carlos
Chagas Filho by Herman Schatzmayr (Instituto Oswaldo
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447CANTAGALO VIRUS, AN EMERGENT POXVIRUSCruz, Rio de Janeiro, RJ, Brazil) and have been stored at
4°C until the present work in which we reconstituted the
contents of an ampule containing each strain in PBS.
Cowpox virus strain Brighton Red was kindly provided by
Richard Moyer (University of Florida, Gainesville, FL) and
was propagated in Hep-2 cells. A specimen of vesicular
fluid from a lesion on a cow during an outbreak in
September, 1999, on a farm in the district Sa˜o Sebastia˜o
o Paraı´ba, Cantagalo County, State of Rio de Janeiro,
razil, was collected and kindly provided to us by Roˆ-
ulo S. Miranda, a veterinarian of the Brazilian Ministry
f Agriculture. The material, subsequently found to con-
ain CTGV, was homogenized in DMEM supplemented
ith 1000 U/ml penicillin, 200 mg/ml streptomycin, and
00 mg/ml gentamycin and clarified by centrifugation at
600 g for 10 min at 4°C, and the supernatant fluid was
sed to inoculate the CAM of 11-day-old chick embryos.
VV-like pock phenotype was determined 4 days postin-
ection; then the infected CAMs were homogenized in
BS and clarified by centrifugation at 1000 g for 10 min at
°C, and the supernatant fluid was used to infect C6 and
ep-2 cells, which were used as stock virus for the
resent studies. Another isolate from a lesion on a
armer during a simultaneously occurring outbreak in
anto Antoˆnio de Pa´dua County was kindly provided by
rtrud Monika Barth (Instituto Oswaldo Cruz, Rio de
aneiro, RJ, Brazil) as the supernatant culture fluid of
nfected Vero cells, from which we also prepared viral
tocks in C6 and Hep-2 cells for the present study.
IMVs were purified as described previously (Mous-
atche´, 1985) from lysates of infected cells by high-speed
entrifugation through a 36% sucrose cushion followed
y IMV sedimentation in 25–40% sucrose gradients. The
umber of virus particles was adjusted to 2 3 1011
particles per milliliter, using the established value of 1
OD260 equals 1.2 3 10
10 particles per milliliter; the IMV
oncentration was determined by plaque assay in
SC-40 cells (Damaso and Moussatche´, 1992).
irus yield analysis
Cell lines were grown in 60-mm-diameter petri dishes,
nfected with CTGV at a multiplicity of 1, and after 1 h, the
nfected monolayers were washed with DMEM and in-
ubated at 37°C under fresh medium for 48 h. Infected
ell monolayers were collected in 500 ml of 4°C sterile
water and submitted to two freeze–thaw cycles. Virus
preparations were diluted in DMEM and a plaque assay
was done in duplicated experiments using BSC-40 cell
monolayers as described previously (Damaso and
Moussatche´, 1992).
Electron microscopy
Hep-2 cells were infected with CTGV (m.o.i. 5 5), and
at 24 h postinfection, the monolayers were washed twice
using PBS at room temperature and then fixed using a
tsolution of 2.5% glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.2, while the cells were adhered to the culture
dish. Fixed cells were scraped, washed in 0.1 M caco-
dylate buffer, and then postfixed for 60 min at 4°C in a
solution of 1% osmium tetroxide in 0.1 M cacodylate
buffer. The cells were then washed in 0.1 M cacodylate
buffer, dehydrated in acetone, and finally embedded in
Epon. Ultrathin sections of the embedded material were
stained using uranyl acetate and lead citrate and ob-
served using a Zeiss CEM-902 electron microscope
(Lanfredi-Rangel et al., 1999).
Antisera and Western blot analyses
Rabbit hyperimmune antiserum against the cowpox
virus acidophilic inclusion body protein (anti-ATI serum)
was kindly provided by David Pickup, Duke University
Medical Center, Durham, North Carolina. Rabbit anti-VV
serum was raised against total proteins of highly purified
VV strain WR (Damaso and Moussatche´, 1998). For West-
ern blot assay, C6 cell monolayers in 35-mm-diameter
petri dishes were separately infected with the different
viruses used at a multiplicity of 1. After a 24-h incubation
at 37°C, infected cell samples were denatured using an
SDS-containing lysis buffer and the proteins in the sam-
ples were separated using SDS–PAGE (10% gels), fol-
lowed by their transfer to nitrocellulose membranes as
described previously (Damaso and Moussatche´, 1998).
The blots were blocked with 5% nonfat dry milk in PBS for
1 h, washed with PBS/0.05% Nonidet-P40, and then in-
cubated with primary antibody diluted 1:8000 (anti-ATI) or
1:2000 (anti-VV) in PBS/5% dry milk for 1 h.
The immunoblots were then washed using PBS/0.05%
Nonidet-P40 prior to incubation for 1 h in a solution of
PBS/0.05% Nonidet-P40/5% dry milk containing goat anti-
rabbit affinity-purified IgG conjugated to horseradish per-
oxidase (1:5000; Amersham/Pharmacia). Viral proteins
were detected by incubation with the ECL Western blot-
ting detection reagents (Amersham/Pharmacia), using
the manufacturer’s protocol. For analysis of purified IMV
proteins, 3 3 109 particles were centrifuged at 12,000 g
or 3 min, and the viral pellet was dissolved in lysis buffer
or SDS–PAGE using 10% gels and Western blotting by
he procedure described above for infected cell lysates.
iral DNA isolation
For PCR amplification and restriction endonuclease
nalysis of genome DNA, C6 monolayers infected at a
ultiplicity of 1 and incubated at 37°C for 48 h were used
o extract viral DNA, essentially as described by Esposito
t al. (1981). A modified protocol was sometimes used to
xtract viral DNA from cell lysates in which the superna-
ant fluid, after low-speed centrifugation to remove nu-
lei, was further centrifuged at 13,000 g for 5 min at 4°Co pellet viral cores. Cores were suspended in 100 ml of
10 mM Tris–HCl, pH 8.0, containing 5 mM EDTA, pH 8.0,
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448 DAMASO ET AL.280 mM 2-mercaptoethanol, 50 mg proteinase K, 5%
sarkosyl, and 25% sucrose. The suspension was incu-
bated for 16 h at 37°C and then extracted twice with
phenol:chloroform:isoamyl alcohol mixture (50:49:1). Fi-
nally, the DNA was precipitated using 2 vol of cold
ethanol and the precipitate was resuspended in 10 mM
Tris buffer for treatment with RNase A and then extracted
twice with the phenol mixture. DNA was extracted from
purified IMVs as described previously (Moussatche´ and
Keller, 1991). Raccoonpox DNA (strain CDC/V71-I-85A)
was isolated as described previously (Knight et al., 1992).
DNA restriction digest and Southern blot analyses
HindIII (Promega) or SalI (BRL/Life Technologies) di-
gests of viral genome DNAs were resolved by electro-
phoresis in 0.6% agarose gels (1.8–3 V/cm) and DNA
digest fragments stained with 0.5 mg/ml ethidium bro-
ide. For Southern blotting, DNA fragments in the gels
ere denatured (Damaso and Moussatche´, 1998), and
ransferred (Sambrook et al., 1989) to Hybond-N mem-
ranes (Amersham/Pharmacia), and then radiolabeled
ick-translated DNAs from purified VV-WR and VV-IOC
ere separately used for cross-hybridization in a form-
mide solution for 18 h at 48°C; blots were washed three
imes at 65°C in 0.13 SSC, 1% SDS (Damaso and Mous-
atche´, 1998).
rimers, PCR, and sequencing
Four pairs of primers (Genemed Synthesis, Inc., S. San
rancisco, CA) were used (Ropp et al., 1995): forward
rimer EACP1 (ATGACACGATTGCCAATAC) and reverse
rimer EACP2 (CTAGACTTTGTTTTCTG) amplify HA DNA
f Eurasian–African orthopoxviruses, and forward primer
ACP1 (ACCGATGTCGTATACTTTGAT) and reverse
rimer NACP2 (GAAACAACTCCAAATATCTC) amplify HA
NA of North American orthopoxviruses. Inspection of
ligned HA sequences reported for other VV strains
nabled design of the additional primers, which we used
o sequence the HA gene of CTGV and VV-IOC: HAINTF
GACATAATACTATCTGGATC), HAINTR (GTGGATTCT-
CAGATGATGC), HAOUTF (CCATTGGAAAAAACACAG-
AC), and HAOUTR (CCAAATATATTCCCATAGTC).
Standard PCR mixtures were 100 ml using manufac-
urer’s buffer containing 25 pmol of primer pair, 250 mM
ach of dATP, dCTP, dTTP, dGTP, 100 ng template, 2.0
nits of Pfu DNA polymerase (Promega). Reactions were
ycled 32 times through denaturation at 94°C for 1 min,
nnealing at 50°C for 1 min, and polymerization at 72°C
or 1 min 30 s using a PTC-100 thermocycler (MJ Re-
earch, Inc.). PCR products were resolved by electro-
horesis in 0.8% agarose gels using TAE buffer [40 mM
ris–acetate (pH 8.0), 1 mM EDTA, and 0.5 mg/ml
ethidium bromide.
The complete HA coding sequence was amplified us-
ing primers HAOUTF and HAOUTR, designed to annealjust outside of the open reading frame to produce
1171-bp amplicons, which were purified using a High-
Pure PCR Product Purification Kit (Boehringer Mann-
heim, Germany). Purified amplicons were sequenced at
the University of Florida Interdisciplinary Center for Bio-
technology Research DNA Sequencing Core Laboratory.
Both strands of DNA were sequenced using the same
primers for amplification plus two other primers, HAINTF
and HAINTR, which anneal in the midregion of the HA
coding sequence, providing overlapping PCR products.
CTGV and VV-IOC sequences in this paper are avail-
able under GenBank Accession Nos. AF229247 and
AF229248, respectively. Other orthopoxvirus HA se-
quences used here were from the DNA of Variola minor
Brazil Garcia 1966 (F72171); VV-L-IVP-1 (CAB11744); VV-
NYBH Wyeth (CAB11749); VV-WR (CAB11744); Rabbitpox
Utrecht (CAB11747); cowpox GRI-90 (CAA75275); Mon-
keypox Zaire 77-0666 (CAB11750); and Ectromelia -K1
(CAB11751). Sequences were analyzed using GCG soft-
ware (Genetic Computer Group); amino acid sequence
alignments were done using GCG Pileup.
Phylogenetic analysis of DNA sequences
Inference of phylogeny of VV-IOC and CTGV HA was
performed by comparing these sequences with HA base
sequences of 14 different orthopoxviruses (Fig. 5) by
using Clustal X to align the base sequences for input into
the maximum-likelihood phylogenetic software Puzzle
4.02 (Strimmer and von Haeseler, 1997). Puzzle software
options included the Hasegawa model of substitution,
neighbor-joining, and a model of uniform rate heteroge-
neity. Buffalopox virus (bfl 81) was chosen to be the
outgroup in performing 10,000 tree-puzzling steps to ob-
tain quartet maximum-likelihood trees to arrive at a quar-
tet puzzling tree with statistically significant taxon parti-
tion frequencies.
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